The Vanguard Group Discloses Position in Spire Healthcare

The Vanguard Group, Inc. has made a disclosure under Rule 8.3 of the Takeover Code, concerning its interests in Spire Healthcare Group plc. The disclosure details Vanguard's position as of 27 February 2026.

Vanguard holds 14,489,978 ordinary shares in Spire Healthcare, representing a 3.60% interest in the company. This position was impacted by the purchase of an additional 22,602 shares at a price of 2.03 GBP per share. No cash-settled or stock-settled derivatives relating to Spire Healthcare are currently held by Vanguard, and no agreements concerning future acquisitions or disposals are in place.

The disclosure confirms that there are no outstanding indemnity or dealing arrangements regarding Spire Healthcare's securities. The document specifies that no other parties are involved in the offer, with no supplemental forms attached.